rs779441513

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001008537.3(NEXMIF):​c.2986A>G​(p.Met996Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,209,804 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.000011 ( 0 hom. 4 hem. )

Consequence

NEXMIF
NM_001008537.3 missense

Scores

16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 2.08

Publications

2 publications found
Variant links:
Genes affected
NEXMIF (HGNC:29433): (neurite extension and migration factor) An inversion on the X chromosome which disrupts this gene and a G-protein coupled purinergic receptor gene located in the pseudoautosomal region of the X chromosome has been linked to X linked cognitive disability.[provided by RefSeq, Mar 2009]
NEXMIF Gene-Disease associations (from GenCC):
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked intellectual disability, Cantagrel type
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • myoclonic-astatic epilepsy
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03320214).
BP6
Variant X-74741571-T-C is Benign according to our data. Variant chrX-74741571-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 578629.
BS2
High Hemizygotes in GnomAdExome4 at 4 Unknown,XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEXMIFNM_001008537.3 linkc.2986A>G p.Met996Val missense_variant Exon 3 of 4 ENST00000055682.12 NP_001008537.1 Q5QGS0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEXMIFENST00000055682.12 linkc.2986A>G p.Met996Val missense_variant Exon 3 of 4 1 NM_001008537.3 ENSP00000055682.5 Q5QGS0
NEXMIFENST00000616200.2 linkc.2986A>G p.Met996Val missense_variant Exon 3 of 5 1 ENSP00000480284.1 Q5QGS0
NEXMIFENST00000642681.2 linkc.2986A>G p.Met996Val missense_variant Exon 3 of 3 ENSP00000495800.1 A0A2R8YEQ5

Frequencies

GnomAD3 genomes
AF:
0.0000179
AC:
2
AN:
111643
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0000325
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00418
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000164
AC:
3
AN:
183018
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000723
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000123
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000109
AC:
12
AN:
1098161
Hom.:
0
Cov.:
32
AF XY:
0.0000110
AC XY:
4
AN XY:
363539
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26398
American (AMR)
AF:
0.00
AC:
0
AN:
35196
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19381
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30203
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54142
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40522
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.0000131
AC:
11
AN:
842086
Other (OTH)
AF:
0.00
AC:
0
AN:
46096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000179
AC:
2
AN:
111643
Hom.:
0
Cov.:
22
AF XY:
0.0000295
AC XY:
1
AN XY:
33849
show subpopulations
African (AFR)
AF:
0.0000325
AC:
1
AN:
30732
American (AMR)
AF:
0.00
AC:
0
AN:
10490
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2653
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3568
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2609
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6046
Middle Eastern (MID)
AF:
0.00418
AC:
1
AN:
239
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53125
Other (OTH)
AF:
0.00
AC:
0
AN:
1500
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
May 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NEXMIF: PM2:Supporting, BP4 -

Jan 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Mar 24, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2986A>G (p.M996V) alteration is located in exon 3 (coding exon 2) of the KIAA2022 gene. This alteration results from a A to G substitution at nucleotide position 2986, causing the methionine (M) at amino acid position 996 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
2.8
DANN
Benign
0.55
DEOGEN2
Benign
0.021
T;T;.
FATHMM_MKL
Benign
0.67
D
LIST_S2
Benign
0.59
.;T;T
M_CAP
Benign
0.0042
T
MetaRNN
Benign
0.033
T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
2.1
PrimateAI
Benign
0.30
T
PROVEAN
Benign
1.1
N;.;.
REVEL
Benign
0.043
Sift
Benign
1.0
T;.;.
Sift4G
Benign
1.0
T;T;.
Polyphen
0.0
B;B;.
Vest4
0.053
MutPred
0.12
Loss of disorder (P = 0.0761);Loss of disorder (P = 0.0761);Loss of disorder (P = 0.0761);
MVP
0.093
MPC
0.23
ClinPred
0.029
T
GERP RS
3.3
Varity_R
0.074
gMVP
0.13
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs779441513; hg19: chrX-73961406; COSMIC: COSV50051408; COSMIC: COSV50051408; API